The dilemma in pausing J J vaccine over risk of blood clots: Will it save lives or cost them

INSUBCONTINENT EXCLUSIVE:

A CDC advisory panel is grappling with the best way to "do no harm" regarding Johnson - Johnson's COVID-19 vaccine and its risk of blood

clots.